By Rachel Cohen, North America Director, DNDi; Michelle Childs, Policy Advocacy Director, DNDi; Monique Wasunna, Eastern Africa Director, DNDi; Michel Lotrowska, Regional Director, DNDi Latin America; Kavita Singh, South Asia Director, DNDi; Nathalie Strub-Wourgaft, Director of Neglected Tropical Diseases (NTDs) and COVID-19 Response, DNDi; Bernard Pécoul, Executive Director, DNDi
The need for treatments at all stages of covid-19 is more pronounced than ever given inequitable access to vaccines and surging cases across different parts of the world, including in Africa, Asia, and Latin America. It is further compounded by the possible waning of immunity over time, uncertainty around the efficacy of vaccines for immune-compromised individuals, vaccine hesitancy, and the continued impact of new variants of concern.
